Overview of Hit to Lead: The Medicinal Chemist's Role from HTS Retest to Lead Optimization Hand Off
暂无分享,去创建一个
[1] Tudor I. Oprea,et al. Quantifying the Relationships among Drug Classes , 2008, J. Chem. Inf. Model..
[2] F. Sams-Dodd. Target-based drug discovery: is something wrong? , 2005, Drug discovery today.
[3] John P. Overington,et al. The Molecular Basis of Predicting Druggability , 2008 .
[4] M. Congreve,et al. A 'rule of three' for fragment-based lead discovery? , 2003, Drug discovery today.
[5] David Brown,et al. Unfinished business: target-based drug discovery. , 2007, Drug discovery today.
[6] A. Hopkins,et al. Ligand efficiency: a useful metric for lead selection. , 2004, Drug discovery today.
[7] P. Leeson,et al. A comparison of physiochemical property profiles of development and marketed oral drugs. , 2003, Journal of medicinal chemistry.
[8] G. V. Paolini,et al. Global mapping of pharmacological space , 2006, Nature Biotechnology.
[9] Peter Ertl,et al. Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds. , 2006, Journal of medicinal chemistry.
[10] P. Leeson,et al. The influence of drug-like concepts on decision-making in medicinal chemistry , 2007, Nature Reviews Drug Discovery.
[11] J. Proudfoot,et al. The evolution of synthetic oral drug properties. , 2005, Bioorganic & medicinal chemistry letters.
[12] Michael M. Hann,et al. RECAP-Retrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry , 1998, J. Chem. Inf. Comput. Sci..
[13] Andreas Bender,et al. Understanding False Positives in Reporter Gene Assays: in Silico Chemogenomics Approaches To Prioritize Cell-Based HTS Data , 2007, J. Chem. Inf. Model..
[14] Michael C. Hutter,et al. Gradual in Silico Filtering for Druglike Substances , 2008, J. Chem. Inf. Model..
[15] H. Verheij,et al. Leadlikeness and structural diversity of synthetic screening libraries , 2006, Molecular Diversity.
[16] Kristin E. D. Coan,et al. Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors. , 2008, Journal of the American Chemical Society.
[17] Tudor I. Oprea,et al. Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..
[18] Renaldo Mendoza,et al. ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens. , 2005, Journal of the American Chemical Society.
[19] John P. Overington,et al. Can we rationally design promiscuous drugs? , 2006, Current opinion in structural biology.
[20] Stuart L. Schreiber,et al. Forward Chemical Genetics , 2008 .